MYX
M PHARMA FPO [MYX]
Healthcare · ASX Small Cap
$2.4650 -2.2%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score -2First seen: 2026-02-25
Score Breakdown
Technical34
Catalyst68
Sentiment50
Fundamental74
Momentum30
Risk Gate47
Active Signals
Bullish Signals
- RSI approaching oversold
- Stochastic oversold
- Cash positive / operating cashflow positive
- Low P/S ratio (0.5x)
- EPS estimates revised upward (+10pts)
- Near 52-week low (1% of range)
- Substantial holder(s) ceased (1)
- Capital raise activity (1 events)
- CANSLIM I: Institutional ownership (24%)
- Severe 12-1 momentum decline (-61%)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
- Trial readout: NA (est. 2019-02-01)
Risk Signals
- MACD momentum weakening
- Price below MAs (downtrend)
- Breakdown below 20-day support
- Below 200-day MA (long-term downtrend)
- Deeply negative margins (-20%)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
Recent Catalysts
HIGH Ceasing to be a substantial holder
NONE Proposed issue of securities - MYX
NONE Final Director's Interest Notice
NONE 2026 Half Year Media Release
LOW 2026 Half Year Investor Presentation
Recent ASX Announcements
| 2026-02-27 | Ceasing to be a substantial holder |
| 2026-02-23 | Proposed issue of securities - MYX |
| 2026-02-23 | Final Director's Interest Notice |
| 2026-02-22 | 2026 Half Year Investor Presentation PRICE SENSITIVE |
| 2026-02-22 | 2026 Half Year Media Release PRICE SENSITIVE |
Key Metrics
$204.7M
Market Cap
388K
Avg Volume
1.1x
Vol Ratio
$2.48 — $7.31
52-Week Range
2.8%
Short Interest
N/A
Cash Runway
-20.6%
ROE
-20.4%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 90% |
| L | Leader vs Laggard | laggard | RS: -5 |
| I | Institutional Sponsorship | pass | Inst: 24% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #56 of 119 · Sector avg: 51
View all Healthcare signals →